Log in to your Inderes Free account to see all free content on this page.
NeoDynamics
Less than 1K followers
NeoDynamics AB (publ) is a Swedish Medical Technology Company dedicated to advancing diagnosis and care of breast cancer. The company’s first product NeoNavia®, a new innovative pulse biopsy system for ultrasound guided tissue sampling, is currently being introduced to the market. The biopsy system is built on a patented pulse technology, based on research at the Karolinska Institutet in Sweden.
Read moreLatest research
Latest analysis report
Released: 22.12.2022
ShowingAll content types
Unofficial trading through Pareto Securities after delisting
NeoDynamics terminates the agreement with liquidity provider
Join Inderes community
Don't miss out - create an account and get all the possible benefits
FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
PREMIUM account
All company reports and content
Premium tools (e.g. insider transactions & stock screener)
Model portfolio
NeoDynamics' stock is delisted from Nasdaq First North
NeoDynamics applies for delisting
Bulletin from the annual general meeting in NeoDynamics AB (publ)
Update on NeoDynamics’ financial situation
NOTICE OF ANNUAL GENERAL MEETING IN NEODYNAMICS AB (PUBL)
NeoDynamics intends to apply for delisting
NeoDynamics Interim Report Jan-March 2024
NeoDynamics publishes Annual Report 2023
Update on NeoDynamics’ management team
Salénterprise increases its shareholding in NeoDynamics.
NeoDynamics announces the final outcome regarding the exercise warrants of series TO3
Update on NeoDynamics’ Management Team
NeoDynamics announces outcome of RIghts issue of shares
